The Dispatch: Jonathan Adler, the Johan Verheij Memorial Professor of Law, noted that the decision on the birth control pill case is expected this summer, and the Supreme Court justices could dismiss the case and sidestep the question of whether the FDA’s regulatory changes are lawful. “If this case is resolved on standing grounds, it will be an important standing decision, but it will resolve very little about the broader issue of abortion and the use or availability of mifepristone,” he said.
Law's Jonathan Adler weighs in on Supreme Court case related to mifepristone
MEDIA |
May 3, 2024
STORY BY: EDITORIAL STAFF
STORY BY: EDITORIAL STAFF